## VRSN: VeriSign, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -3.2% below STRENGTH zone (4.0-10.0%); PEG 2.75 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($230.28)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 31 ($4.76M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+8.1%)
- Blackrock Inc.: 10.5% (+6.5%)
- Berkshire Hathaway, : 9.7% (-32.4%)
- State Street Corpora: 4.6% (+8.2%)
- Ninety One UK Ltd: 4.6% (+53.6%)

### Key Risks

1. Insider selling cluster: $4.8M in recent transactions.
2. Long-term trend broken: trading 8.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.75 signals overvaluation risk, limited margin of safety. Forward P/E 25.5x stretched relative to 7% growth. Quality metrics strong (ROA 48%, margin 50%). Insider selling cluster ($4.8M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.6B |
| Beta | 0.78 |
| 52W Range | $191.12 - $310.60 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.75 |
| Forward P/E | 25.5 |
| Current P/E | 27.3 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.8% to -3.2% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.4%) - potential reversal signal. Underperforming sector by 3.2pp, stock-specific weakness. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram bearish (-0.65), momentum weakening. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.24% (CS: 14) | Weak |
| RSI_14 | 39.7 | Neutral |
| MACD Histogram | -0.65 | Bearish |
| vs SMA20 | 0.971x | Below |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 0.911x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $242.00
- **Stop Loss:** $230.28 (4.8% risk)
- **Target:** $253.72 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 85
- **Position Value:** $20,570.00
- **Portfolio %:** 20.57%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-05 (Est: $2.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.24 | $2.27 | +1.3% |
| 2025Q2 | $2.18 | $2.21 | +1.4% |
| 2025Q1 | $2.09 | $2.10 | +0.5% |
| 2024Q4 | $2.01 | $2.00 | -0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*